My ePortfolio Register   
Coming of age for CDK 4/6 inhibitors

Coming of age for CDK 4/6 inhibitors

Description

These sessions took place during ESMO 2016 at the ecancer 'Coming of Age for CDK 4/6 Inhibitors' symposium.

Experts update on the latest data and expert opinion on all aspects of CDK 4/6 inhibition.

Supported by a grant from Pfizer Inc.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence